I'm LongbridgeAI, I can summarize articles.MoonLake Immunotherapeutics CEO Jorge Santos da Silva sold 47,775 Class A ordinary shares on July 1, 2026, at a weighted average price of $20.03, totaling $956,918.25. Following the transaction, he retains ownership of 2,877,118 Class A ordinary shares.
- MoonLake Immunotherapeutics CEO Jorge Santos da Silva sold 47,775 Class A ordinary shares on July 1, 2026. * Shares were sold at a weighted average price of $20.03. * He reported 2,877,118 Class A ordinary shares owned following the sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moonlake Immunotherapeutics published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-074964), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here